This article is a review of the literature published during the 12 months of 2016 that are of interest to the congenital cardiac anesthesiologist. Five themes are addressed for 2016, and 53 peer-reviewed articles are discussed.
IngRJTwiteMD. The year in review: anesthesia for congenital heart disease 2013. Semin Cardiothorac Vasc Anesth. 2014;18:17-23.
2.
IngRJTwiteMD. The year in review: anesthesia for congenital heart disease 2014. Semin Cardiothorac Vasc Anesth. 2015;19:12-20.
3.
TwiteMIngRJ. Noteworthy literature in 2015: anesthesia for congenital heart disease. Semin Cardiothorac Vasc Anesth. 2016;20:14-23.
4.
WaldoKLKumiskiDHWallisKT. Conotruncal myocardium arises from a secondary heart field. Development. 2001;128:3179-3188.
5.
MjaatvedtCHNakaokaTMoreno-RodriguezR. The outflow tract of the heart is recruited from a novel heart-forming field. Dev Biol. 2001;238:97-109.
6.
KellyRGBrownNABuckinghamME. The arterial pole of the mouse heart forms from Fgf10-expressing cells in pharyngeal mesoderm. Dev Cell. 2001;1:435-440.
7.
DyerLAKirbyML. The role of secondary heart field in cardiac development. Dev Biol. 2009;336:137-144.
8.
KloeselBDiNardoJABodySC. Cardiac embryology and molecular mechanisms of congenital heart disease: a primer for anesthesiologists. Anesth Analg. 2016;123:551-569.
9.
MunteanIToganelRBenedekT. Genetics of congenital heart disease: past and present [published online November 2, 2016]. Biochem Genet. doi:10.1007/s10528-016-9780-7.
10.
WehmanBSharmaSPietrisN. Mesenchymal stem cells preserve neonatal right ventricular function in a porcine model of pressure overload. Am J Physiol Heart Circ Physiol. 2016;310:H1816-H1826.
11.
AgarwalUSmithAWFrenchKM. Age-dependent effect of pediatric cardiac progenitor cells after juvenile heart failure. Stem Cells Transl Med. 2016;5:883-892.
BiermannDEderAArndtF. Towards a tissue-engineered contractile Fontan-conduit: the fate of cardiac myocytes in the subpulmonary circulation. PLoS One. 2016;11:e0166963.
14.
SerioPFainardiVLeoneR. Tracheobronchial obstruction: follow-up study of 100 children treated with airway stenting. Eur J Cardiothorac Surg. 2014;45:e100-e109.
15.
SerioPNennaRFainardiV. Residual tracheobronchial malacia after surgery for vascular compression in children: treatment with stentingdagger [published online October 15, 2016]. Eur J Cardiothorac Surg. doi:10.1093/ejcts/ezw299.
16.
LischkeRPozniakJVondrysDElliottMJ. Novel biodegradable stents in the treatment of bronchial stenosis after lung transplantation. Eur J Cardiothorac Surg. 2011;40:619-624.
17.
VondrysDElliottMJMcLarenCANoctorCRoebuckDJ. First experience with biodegradable airway stents in children. Ann Thorac Surg. 2011;92:1870-1874.
18.
NovotnyLCrhaMRauserP. Novel biodegradable polydioxanone stents in a rabbit airway model. J Thorac Cardiovasc Surg. 2012;143:437-444.
19.
MorrisonRJHollisterSJNiednerMF. Mitigation of tracheobronchomalacia with 3D-printed personalized medical devices in pediatric patients. Sci Transl Med. 2015;7:285ra64.
20.
Anton-PachecoJLLunaCGarciaE. Initial experience with a new biodegradable airway stent in children: is this the stent we were waiting for?Pediatr Pulmonol. 2016;51:607-612.
21.
HoskoteACohenGGoldmanAShekerdemianL. Tracheostomy in infants and children after cardiothoracic surgery: indications, associated risk factors, and timing. J Thorac Cardiovasc Surg. 2005;130:1086-1093.
22.
ProdhanPAgarwalAElHassanNO. Tracheostomy among infants with hypoplastic left heart syndrome undergoing cardiac operations: a multicenter analysis [published online November 16, 2016]. Ann Thorac Surg. doi:10.1016/j.athoracsur.2016.09.016.
23.
MossadEYoussefG. Subglottic stenosis in children undergoing repair of congenital heart defects. J Cardiothorac Vasc Anesth. 2009;23:658-662.
24.
DeMicheleJCVajariaNWangHSweeneyDMPowersKSCholetteJM. Cuffed endotracheal tubes in neonates and infants undergoing cardiac surgery are not associated with airway complications. J Clin Anesth. 2016;33:422-427.
25.
LitmanRSMaxwellLG. Cuffed versus uncuffed endotracheal tubes in pediatric anesthesia: the debate should finally end. Anesthesiology. 2013;118:500-501.
26.
ChiuJSZuckermanWATurnerME. Balloon atrial septostomy in pulmonary arterial hypertension: effect on survival and associated outcomes. J Heart Lung Transplant. 2015;34:376-380.
27.
HopperRKAbmanSHIvyDD. Persistent challenges in pediatric pulmonary hypertension. Chest. 2016;150:226-236.
28.
IvyD. Pulmonary hypertension in children. Cardiol Clin. 2016;34:451-472.
29.
NasrVGFaraoniDDiNardoJAThiagarajanRR. Adverse outcomes in neonates and children with pulmonary artery hypertension supported with ECMO. ASAIO J. 2016;62:728-731.
30.
GalieNHoeperMMHumbertM. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30:2493-2537.
31.
GradyRMEghtesadyP. Potts shunt and pediatric pulmonary hypertension: what we have learned. Ann Thorac Surg. 2016;101:1539-1543.
32.
KulaSAtasayanV. Surgical and transcatheter management alternatives in refractory pulmonary hypertension: Potts shunt. Anatol J Cardiol. 2015;15:843-847.
33.
SizarovARaimondiFBonnetDBoudjemlineY. Vascular anatomy in children with pulmonary hypertension regarding the transcatheter Potts shunt. Heart. 2016;102:1735-1741.
34.
SchranzD. Potts shunt for pulmonary hypertension: the interventionist’s interest in imaging. Heart. 2016;102:1699-1700.
35.
AmirG. In search of ideal surgical palliation for drug refractory pulmonary hypertension. Eur J Cardiothorac Surg. 2015;47:e110-e112.
36.
ApitzCHansmannGSchranzD. Hemodynamic assessment and acute pulmonary vasoreactivity testing in the evaluation of children with pulmonary vascular disease: expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK. Heart. 2016;102(suppl 2):ii23-ii29.
37.
BeghettiMBergerRMSchulze-NeickI. Diagnostic evaluation of paediatric pulmonary hypertension in current clinical practice. Eur Respir J. 2013;42:689-700.
38.
SiehrSLFeinsteinJAYangWPengLFOgawaMTRamamoorthyC. Hemodynamic effects of phenylephrine, vasopressin, and epinephrine in children with pulmonary hypertension: a pilot study. Pediatr Crit Care Med. 2016;17:428-437.
39.
LatalB. Neurodevelopmental outcomes of the child with congenital heart disease. Clin Perinatol. 2016;43:173-185.
40.
RollinsCKAsaroLAAkhondi-AslA. White matter volume predicts language development in congenital heart disease [published online November 9, 2016]. J Pediatr. doi:10.1016/j.jpeds.2016.09.070.
41.
SeltzerLSwartzMFKwonJ. Neurodevelopmental outcomes after neonatal cardiac surgery: role of cortical isoelectric activity. J Thorac Cardiovasc Surg. 2016;151:1137-1142.
42.
CalderonJStoppCWypijD. Early-term birth in single-ventricle congenital heart disease after the Fontan procedure: neurodevelopmental and psychiatric outcomes. J Pediatr. 2016;179:96-103.
43.
KloudaLFranklinWJSarafAParekhDRSchwartzDD. Neurocognitive and executive functioning in adult survivors of congenital heart disease [published online September 16, 2016]. Congenit Heart Dis. doi:10.1111/chd.12409.
44.
AlySAZurakowskiDGlassPSkurow-ToddKJonasRADonofrioMT. Cerebral tissue oxygenation index and lactate at 24 hours postoperative predict survival and neurodevelopmental outcome after neonatal cardiac surgery [published online November 10, 2016]. Congenit Heart Dis. doi:10.1111/chd.12426.
45.
CharDRamamoorthyCWise-FaberowskiL. Cognitive dysfunction in children with heart disease: the role of anesthesia and sedation. Congenit Heart Dis. 2016;11:221-229.
46.
VutskitsLXieZ. Lasting impact of general anaesthesia on the brain: mechanisms and relevance. Nat Rev Neurosci. 2016;17:705-717.
47.
De RooMKlauserPBrinerA. Anesthetics rapidly promote synaptogenesis during a critical period of brain development. PLoS One. 2009;4:e7043.
48.
MillerSPMcQuillenPSHamrickS. Abnormal brain development in newborns with congenital heart disease. N Engl J Med. 2007;357:1928-1938.
49.
FordMAGauvreauKMcMullanDM. Factors associated with mortality in neonates requiring extracorporeal membrane oxygenation for cardiac indications: analysis of the Extracorporeal Life Support Organization Registry Data. Pediatr Crit Care Med. 2016;17:860-870.
50.
BoscampNSTurnerMECrystalMAndersonBVincentJATorresAJ. Cardiac catheterization in pediatric patients supported by extracorporeal membrane oxygenation: a 15-year experience [published online November 21, 2016]. Pediatr Cardiol. doi:10.1007/s00246-016-1518-0.
51.
ChopskiSGMoskowitzWBStevensRMThrockmortonAL. Mechanical circulatory support devices for pediatric patients with congenital heart disease [published online November 8, 2016]. Artif Organs. doi:101111/aor12760.
52.
WangDGaoGPlunkettM. A paired membrane umbrella double-lumen cannula ensures consistent cavopulmonary assistance in a Fontan sheep model. J Thorac Cardiovasc Surg. 2014;148:1041-1047, discussion 1047.
53.
FleckTPDangelGBachleF. Long-term follow-up on health-related quality of life after mechanical circulatory support in children [published online November 15, 2016]. Pediatr Crit Care Med. doi:101097/PCC0000000000001019.
